Coherus Oncology公司
US ˙ NasdaqGM ˙ US19249H1032

SecurityCHRS / Coherus Oncology, Inc.
InstitutionInvesco Ltd.
Latest Disclosed Ownership335,309 shares
Latest Disclosed Value $ 566,672
Invesco Ltd. reports 11.77% decrease in ownership of CHRS / Coherus Oncology, Inc.

On May 12, 2026 - Invesco Ltd. filed a 13F-HR form disclosing ownership of 335,309 shares of Coherus Oncology, Inc. (US:CHRS) valued at $566,672 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 19, 2026 disclosing 380,033 shares of Coherus Oncology, Inc.. This represents a change in shares of -11.77% during the quarter. The current value of the position is $528,112 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-12 2026-03-31 13F COHERUS ONCOLOGY COM 19249H103 335,309 -44,724 -11.77 567 5.01 0.0000
2026-02-19 2025-12-31 13F COHERUS ONCOLOGY COM 19249H103 380,033 119,041 45.61 540 25.93 0.0001
2025-11-13 2025-09-30 13F COHERUS ONCOLOGY COM 19249H103 260,992 52,721 25.31 428 181.58 0.0001
2025-08-13 2025-06-30 13F COHERUS ONCOLOGY COM 19249H103 208,271 21,550 11.54 152 1.33 0.0000
2025-05-12 2025-03-31 13F COHERUS BIOSCIENCES COM 19249H103 186,721 120,670 182.69 151 64.84 0.0000
2025-02-13 2024-12-31 13F COHERUS BIOSCIENCES COM 19249H103 66,051 4,822 7.88 91 44.44 0.0000
2024-11-12 2024-09-30 13F COHERUS BIOSCIENCES COM 19249H103 61,229 9,128 17.52 64 -30.00 0.0000
2024-08-13 2024-06-30 13F COHERUS BIOSCIENCES COM 19249H103 52,101 4,788 10.12 90 -20.35 0.0000
2024-05-14 2024-03-31 13F COHERUS BIOSCIENCES COM 19249H103 47,313 -84 -0.18 113 -28.03 0.0000
2024-02-13 2023-12-31 13F COHERUS BIOSCIENCES COM 19249H103 47,397 9,311 24.45 158 10.56 0.0000
2023-11-13 2023-09-30 13F COHERUS BIOSCIENCES COM 19249H103 38,086 -238,074 -86.21 142 -87.96 0.0000
2023-08-11 2023-06-30 13F COHERUS BIOSCIENCES COM 19249H103 276,160 -5,985 -2.12 1,179 -38.88 0.0003
2023-05-12 2023-03-31 13F COHERUS BIOSCIENCES COM 19249H103 282,145 -59,708 -17.47 1,930 -28.74 0.0005
2023-02-13 2022-12-31 13F COHERUS BIOSCIENCES COM 19249H103 341,853 26,220 8.31 2,707 -10.75 0.0008
2022-11-14 2022-09-30 13F COHERUS BIOSCIENCES COM 19249H103 315,633 -17,160 -5.16 3,033 25.90 0.0010
2022-08-15 2022-06-30 13F COHERUS BIOSCIENCES COM 19249H103 332,793 4,465 1.36 2,409 -43.17 0.0007
2022-05-16 2022-03-31 13F COHERUS BIOSCIENCES COM 19249H103 328,328 19,909 6.46 4,239 -13.88 0.0011
2022-02-14 2021-12-31 13F COHERUS BIOSCIENCES COM 19249H103 308,419 -111,901 -26.62 4,922 -27.14 0.0012
2021-11-15 2021-09-30 13F COHERUS BIOSCIENCES COM 19249H103 420,320 -36,718 -8.03 6,755 6.87 0.0017
2021-08-17 2021-06-30 13F COHERUS BIOSCIENCES COM 19249H103 457,038 23,276 5.37 6,321 -0.25 0.0016
2021-05-17 2021-03-31 13F COHERUS BIOSCIENCES COM 19249H103 433,762 -548,803 -55.85 6,337 -62.89 0.0017
2021-02-16 2020-12-31 13F COHERUS BIOSCIENCES COM 19249H103 982,565 60,004 6.50 17,077 0.93 0.0050
2020-11-16 2020-09-30 13F COHERUS BIOSCIENCES COM 19249H103 922,561 -56,350 -5.76 16,920 -3.21 0.0057
2020-08-14 2020-06-30 13F COHERUS BIOSCIENCES COM 19249H103 978,911 75,389 8.34 17,482 19.30 0.0063
2020-05-15 2020-03-31 13F COHERUS BIOSCIENCES COM 19249H103 903,522 608,983 206.76 14,654 176.28 0.0062
2020-02-14 2019-12-31 13F COHERUS BIOSCIENCES COM 19249H103 294,539 -422,783 -58.94 5,304 -63.50 0.0016
2019-11-14 2019-09-30 13F COHERUS BIOSCIENCES COM 19249H103 717,322 294,236 69.55 14,533 55.43 0.0038
2019-08-14 2019-06-30 13F/A-1 COHERUS BIOSCIENCES COM 19249H103 423,086 40,787 10.67 9,350 79.29 0.0024
2019-08-14 2019-06-30 13F COHERUS BIOSCIENCES COM 19249H103 423,086 -92,485 9,350
2019-05-15 2019-03-31 13F COHERUS BIOSCIENCES COM 19249H103 382,299 382,299 5,215 0.0018
2015-11-16 2015-09-30 13F COHERUS BIOSCIENCES COMMON 19249H103 0 -197 -100.00 0 -100.00
2015-08-14 2015-06-30 13F COHERUS BIOSCIENCES COMMON 19249H103 197 197 6 0.0000
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.